For Hospitals & Health Systems
Support Care Before Surgery. Stay Connected After Discharge.
CuraVeyra is designed to support selected monitoring programmes before planned procedures and during recovery at home. Longitudinal vital signs, reported symptoms and available clinical context can help authorized teams recognize changes that warrant review and coordinate the next step.
Before, during & beyond hospital care
One Patient Journey. Three Connected Stages.
- 01
Before the Procedure
Selected home measurements and symptom reports can provide additional context between clinical assessment and a planned procedure. Significant changes can be brought to the attention of the responsible team.
Supports clinical assessment; does not replace required preoperative examinations or determine fitness for surgery.
- 02
At Discharge
A defined monitoring plan can bring together the discharge baseline, selected measurements, alert rules, responsible recipients and follow-up arrangements.
- 03
Recovery at Home
Teams can review recovery trends, reported symptoms and missing measurements, assess alerts and decide whether patient contact, a clinical review or further care is appropriate.
Measurements, frequency and response arrangements are defined by the clinical programme and supported device integrations.
Potential organizational benefits
A clearer view. A coordinated next step.
Clinical continuity
- Visibility into patient trends before and after hospital care.
- Earlier recognition of changes that warrant assessment.
- Structured follow-up with documented outcomes.
Operational coordination
- Prioritized review of patients requiring attention.
- Defined alert ownership and acknowledgment tracking.
- A shared record of measurements, contact attempts and incident history.
Economic value to evaluate
- Potential to reduce avoidable emergency visits and unplanned readmissions.
- Potential to support more effective use of hospital capacity.
- Evaluation of programme costs alongside staff workload and clinical outcomes.
Potential benefits, not demonstrated CuraVeyra outcomes. Net value depends on the patient population, care pathway, response model and programme costs.
Recognize change. Support clinical review.
Earlier insight. Human decisions.
The goal is to recognize early signs of deterioration before they develop into a more serious complication. Developing AI capabilities aim to support risk-pattern recognition and require clinical validation.
Recorded changes
Longitudinal measurements, reported symptoms and gaps in recorded data provide context for review.
AI risk-pattern support
Planned predictive support is an analytical layer over platform records, not a validated determination of future complications.
Clinical-team decisions
Authorized professionals assess the available evidence and decide the next step according to the care programme.
Not every complication can be prevented. A clinically necessary hospital admission may be the appropriate outcome of an early response.
Pilot Program
Start focused. Measure what matters.
All figures below are pilot planning targets, not completed outcomes. Pilots are subject to agreements, approvals and applicable regulatory requirements.
Proposed Cardiology Pilot
- BP, SpO₂, weight and selected ECG events
- Protocol-based monitoring
- Clinical oversight by authorized professionals
Proposed Senior Care Pilot
- Vital-sign tracking
- Caregiver notifications
- Safety and incident monitoring
Metrics to evaluate
Programme feasibility
- Measurement adherence and data availability.
- Time to alert acknowledgment and clinical review.
- Alert relevance and staff workload.
Clinical and economic outcomes to evaluate
- Unplanned readmissions and emergency visits within a defined follow-up period.
- Escalation outcomes and patient safety.
- Total programme cost, including devices, integration and clinical response.
A small initial pilot can establish feasibility and refine the workflow. Demonstrating changes in readmissions or cost requires an appropriately designed evaluation.
Discuss a Clinical Pilot
Define a focused patient group, a clear monitoring pathway and measurable goals with our team.